23:03 25/11/2014 Robbins Arroyo LLP: Aeterna Zentaris Inc. (AEZS) Misled Shareholders ...
Robbins Arroyo LLP: Aeterna Zentaris Inc. (AEZS) Misled Shareholders ...
GlobeNewswire (press release) - 18 hours ago
SAN DIEGO and QUEBEC CITY, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Aeterna Zentaris Inc. (Nasdaq:AEZS) has filed a federal securities fraud class action complaint in the U.S. ...

17:26 21/11/2014 SHAREHOLDER ALERT: Class Action Lawsuit Against Aeterna Zentaris Inc ...
SHAREHOLDER ALERT: Class Action Lawsuit Against Aeterna Zentaris Inc ...
Business Wire (press release) - Nov 21, 2014
LOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP, representing investors of Aeterna Zentaris Inc. (“Aeterna” or the “Company”) (NASDAQ:AEZS), has filed a class action lawsuit in the United States District Court for the District of New Jersey ...

12:56 19/11/2014 How Risky is Your Portfolio? AEterna Zentaris Inc. (AEZS), Ascena Retail Group ...
How Risky is Your Portfolio? AEterna Zentaris Inc. (AEZS), Ascena Retail Group ...
Investor Wired (press release) - Nov 19, 2014
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) has the market capitalization of $32.23 million while 58.21 million shares were outstanding.

13:41 18/11/2014 Healthcare Stock's Trend Analysis Report - AEterna Zentaris Inc. (USA) (AEZS ...
Healthcare Stock's Trend Analysis Report - AEterna Zentaris Inc. (USA) (AEZS ...
Techsonian (press release) - Nov 18, 2014
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced fiscal and operating results for the third quarter ended September 30, 2014 .

15:35 17/11/2014 Notice of Filing of Securities Fraud Class Action against Aeterna Zentaris Inc ...
Notice of Filing of Securities Fraud Class Action against Aeterna Zentaris Inc ...
MarketWatch - Nov 17, 2014
... 2014 (BUSINESS WIRE) -- Abraham, Fruchter & Twersky, LLP has filed a securities fraud class action against Aeterna Zentaris Inc. (“Aeterna Zentaris” or the “Company”) AEZS, +0.57% and certain of its senior executives in the United States District ...

15:45 10/11/2014 Concerning Biotech Stocks- AEterna Zentaris Inc. (USA) (NASDAQ:AEZS ...
Concerning Biotech Stocks- AEterna Zentaris Inc. (USA) (NASDAQ:AEZS ...
StreetWise Report - Nov 10, 2014
Law Offices of Howard G. Smith declares that it is investigating potential claims on behalf of shareholders of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS). The inquiry concerns possible destructions of federal securities laws and emphases on certain ...
Mid-Day Movers –AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Quicksilver ... - Techsonian (press release)
Most Active Stocks: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Arrowhead ... - Market News Call

12:27 10/11/2014 Top Movers Report: RF Micro Devices (NASDAQ:RFMD), AEterna Zentaris Inc ...
Top Movers Report: RF Micro Devices (NASDAQ:RFMD), AEterna Zentaris Inc ...
Markets Emerging - Nov 10, 2014
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) tumbled 12.77% to new low after the Food and Drug Administration rejected its growth hormone test.
New Lows Stocks at Healthcare: Aeterna Zentaris Inc. (NASDAQ:AEZS), Cytori ... - eMarketsDaily

19:07 07/11/2014 Special News Alert: Vapor Corp.,(NASDAQ:VPCO), AEterna Zentaris Inc. (USA ...
Special News Alert: Vapor Corp.,(NASDAQ:VPCO), AEterna Zentaris Inc. (USA ...
Market News Call - Nov 7, 2014
Lakeway, NY - (MARKET NEWS CALL) - 11/07/2014— Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on ...

17:03 07/11/2014 Most Active Biotechnology Movers: AEterna Zentaris Inc. (USA)(NASDAQ:AEZS ...
Most Active Biotechnology Movers: AEterna Zentaris Inc. (USA)(NASDAQ:AEZS ...
StreetWise Report - Nov 7, 2014
The Rosen Law Company declares that it is examining potential securities scam claims against AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) resultant from its statement that the FDA would not authorize its New Medicine Application. The Corporation ...

12:45 06/11/2014 Aeterna hits record low after FDA rejects growth hormone test
Aeterna hits record low after FDA rejects growth hormone test
Reuters - Nov 6, 2014
(Reuters) - Canada's Aeterna Zentaris Inc said the U.S. Food and Drug Administration rejected macimorelin, which the drugmaker had hoped would be the first orally administered drug to determine if adults had growth hormone deficiency.
Investors Alert: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Exelixis, Inc ... - Market News Call
FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen™ NDA in ... - MarketWatch